Pacira’s (PCRX) Q3 Earnings Beat Estimates, Revenues Miss Mark

Pacira’s (PCRX) earnings beat estimates in the third quarter of 2021 while revenues miss the same. Its flagship product Exparel’s sales rise year over year.

Leave a comment

Your email address will not be published. Required fields are marked *